Hazlett, Burt & Watson’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11K Hold
142
﹤0.01% 677
2025
Q4
$12K Sell
142
-40
-22% -$3.12K ﹤0.01% 677
2025
Q3
$15K Buy
182
+86
+90% +$6.41K 0.01% 609
2025
Q2
$7K Sell
96
-238
-71% -$16.6K ﹤0.01% 635
2025
Q1
$27K Sell
334
-387
-54% -$33.3K 0.01% 453
2024
Q4
$57K Hold
721
0.03% 345
2024
Q3
$67K Buy
721
+639
+779% +$53.6K 0.03% 318
2024
Q2
$7K Sell
82
-23
-22% -$1.88K ﹤0.01% 551
2024
Q1
$9K Sell
105
-15
-13% -$1.25K 0.01% 522
2023
Q4
$10K Sell
120
-333
-74% -$23.3K 0.01% 496
2023
Q3
$31K Buy
453
+1
+0.2% +$73 0.02% 361
2023
Q2
$37K Sell
452
-19
-4% -$1.52K 0.03% 342
2023
Q1
$39K Buy
+471
New +$33.6K 0.03% 310

Other funds holding GEHC

Hazlett, Burt & Watson's GEHC Position: Q1 2026 in Review

Hazlett, Burt & Watson held its GE HealthCare (GEHC) position steady in Q1 2026 at 142 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #677.

Hazlett, Burt & Watson first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $67K in Q3 2024. 1,265 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Hazlett, Burt & Watson held 142 shares of GE HealthCare worth $11K as of Q1 2026.
  • Hazlett, Burt & Watson left its GE HealthCare share count unchanged in Q1 2026.
  • GE HealthCare made up ﹤0.01% of Hazlett, Burt & Watson's portfolio in Q1 2026, its #677 holding.
  • Hazlett, Burt & Watson first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • Hazlett, Burt & Watson's GE HealthCare position peaked at $67K in Q3 2024.
  • 1,265 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q1 2026, filed 14 May 2026.